ANI Pharmaceuticals, Inc. announced that it has acquired the new drug applications for OXISTAT® Lotion, VEREGEN® Ointment, and Pandel® Cream and the abbreviated new drug application for ApexiCon® E Cream from Sandoz Inc. Pandel® Cream will be transitioned later upon receiving the requisite approvals.
April 6, 2021
· 4 min read